Knight Therapeutics Inc. (GUD.TO)
CAD 5.21
(-0.19%)
CAD 5.21
(-0.19%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.16 CAD | 38.46% |
| 2022 | -0.26 CAD | -300.0% |
| 2021 | 0.13 CAD | -45.83% |
| 2020 | 0.24 CAD | 140.0% |
| 2019 | 0.10 CAD | -41.18% |
| 2018 | 0.17 CAD | 41.67% |
| 2017 | 0.12 CAD | -20.0% |
| 2016 | 0.15 CAD | -58.33% |
| 2015 | 0.36 CAD | -83.64% |
| 2014 | 2.20 CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.02 CAD | 57.24% |
| 2024 Q1 | -0.04 CAD | 81.29% |
| 2023 Q2 | 0.02 CAD | 148.16% |
| 2023 FY | - CAD | 38.46% |
| 2023 Q4 | -0.24 CAD | -366.08% |
| 2023 Q3 | 0.09 CAD | 430.59% |
| 2023 Q1 | -0.04 CAD | 74.79% |
| 2022 Q2 | 0.02 CAD | 113.69% |
| 2022 FY | - CAD | -300.0% |
| 2022 Q4 | -0.14 CAD | -1107.19% |
| 2022 Q3 | 0.01 CAD | -36.53% |
| 2022 Q1 | -0.16 CAD | -125.99% |
| 2021 Q2 | 0.23 CAD | 666.67% |
| 2021 Q1 | 0.03 CAD | -53.13% |
| 2021 Q4 | -0.07 CAD | -1.14% |
| 2021 FY | - CAD | -45.83% |
| 2021 Q3 | -0.07 CAD | -130.43% |
| 2020 Q2 | 0.13 CAD | 1131.75% |
| 2020 FY | - CAD | 140.0% |
| 2020 Q3 | 0.14 CAD | 7.69% |
| 2020 Q4 | 0.06 CAD | -54.29% |
| 2020 Q1 | -0.01 CAD | 74.44% |
| 2019 Q2 | 0.13 CAD | 225.0% |
| 2019 Q1 | 0.04 CAD | 2566.67% |
| 2019 Q4 | -0.05 CAD | -129.3% |
| 2019 FY | - CAD | -41.18% |
| 2019 Q3 | -0.02 CAD | -116.54% |
| 2018 FY | - CAD | 41.67% |
| 2018 Q4 | 0.00 CAD | -98.35% |
| 2018 Q2 | 0.03 CAD | -44.0% |
| 2018 Q1 | 0.05 CAD | 0.0% |
| 2018 Q3 | 0.09 CAD | 225.0% |
| 2017 Q3 | 0.02 CAD | 733.33% |
| 2017 Q2 | 0.00 CAD | -92.5% |
| 2017 Q1 | 0.04 CAD | -28.57% |
| 2017 FY | - CAD | -20.0% |
| 2017 Q4 | 0.05 CAD | 100.0% |
| 2016 FY | - CAD | -58.33% |
| 2016 Q1 | 0.01 CAD | -90.74% |
| 2016 Q4 | 0.06 CAD | 40.0% |
| 2016 Q2 | 0.04 CAD | 680.0% |
| 2016 Q3 | 0.04 CAD | 2.56% |
| 2015 Q3 | 0.07 CAD | -22.22% |
| 2015 Q4 | 0.05 CAD | -22.86% |
| 2015 FY | - CAD | -83.64% |
| 2015 Q1 | 0.15 CAD | -88.89% |
| 2015 Q2 | 0.09 CAD | -40.0% |
| 2014 Q4 | 1.35 CAD | 19185.71% |
| 2014 Q3 | 0.01 CAD | 16.67% |
| 2014 Q2 | 0.01 CAD | 163.83% |
| 2014 Q1 | -0.01 CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | 0.01 CAD | 0.0% |
| 2012 Q3 | 0.00 CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aurora Cannabis Inc. | -1.60 CAD | 90.0% |
| Avicanna Inc. | -0.09 CAD | -71.858% |
| Avant Brands Inc. | -0.61 CAD | 73.77% |
| Cardiol Therapeutics Inc. | -0.44 CAD | 63.636% |
| Crescita Therapeutics Inc. | -0.10 CAD | -63.265% |
| MediPharm Labs Corp. | -0.04 CAD | -344.444% |
| OrganiGram Holdings Inc. | -2.82 CAD | 94.326% |
| Canopy Growth Corporation | -8.79 CAD | 98.18% |
| Willow Biosciences Inc. | -0.10 CAD | -60.0% |
| Auxly Cannabis Group Inc. | -0.04 CAD | -256.347% |